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ABSTRACT Transformation of cells in tissue culture
results in a variety of cellular changes including alterations in
cell growth, adhesiveness, motility, morphology, and organi-
zation of the cytoskeleton. Morphological and cytoskeletal
changes are perhaps the most readily apparent features of
transformed cells. Although a number of studies have docu-
mented a decrease in the expression of specific tropomyosin
(TM) isoforms in transformed cells, it remains to be deter-
mined if the suppression of TM synthesis is essential in the
establishment and maintenance of the transformed pheno-
type. To address the roles of different TM isoforms in trans-
formed cells we have examined the effects of expressing
specific TM isoforms in transformed cells using a Kirsten
virus-transformed cell line (ATCC NRK 1569) as a model
system. In contrast to normal fibroblasts, the NRK 1569 cells
contain reduced levels of TM-1 and undetectable levels of
TM-2 and TM-3. These cells have a rounded morphology and
are devoid of stress ribers. Employing expression plasmids for
TM-2 and TM-3, stable cell lines were established from the
NRK 1569 cells that express these isoforms individually. We
demonstrate that expression of TM-2 or TM-3 leads to in-
creased cell spreading accompanied by the formation of
identifiable microfilament bundles, as well as significant
restoration of well-defined vinculin-containing focal adhesion
plaques, although expression of each isoform exhibited dis-
tinct properties. In addition, cells expressing TM-2, but not
TM-3, exhibited contact-inhibited cell growth and a require-
ment for serum.
Malignant transformation of cells is commonly accompanied
by a variety of morphological changes such as rounded cell
shape, a poorly organized microfilament system, alterations in
locomotory activity, and a reduced cell-substrate adhesion.
Morphological changes are perhaps the most striking feature
of transformed cells. These changes in cell shape are clearly
associated with the cytoskeleton. Immunofluorescence and
electron microscopic studies have shown that transformed cells
exhibit profound changes in the organization of microfila-
ments. Such studies reveal that microfilament bundles exist in
a more dispersed state and are reduced in size and number in
transformed cells. In addition, changes in microfilament struc-
ture are highly related to both anchorage-independent growth
and cellular tumorigenicity (1), suggesting a role for micro-
filament alteration in oncogenic transformation. The molec-
ular, biochemical, and structural bases for these alterations of
microfilament cables in transformed cells are poorly under-
stood. The altered expression of a number of individual
cytoskeletal proteins have been implicated in the transformed
phenotype including actin, tropomyosin (TM), gelsolin, caldes-
mon, and myosin light chain (reviewed in ref. 2).
A number of studies have demonstrated that TM expression
is selectively altered in several transformed cells (3-13). In
general, these experiments demonstrate that in transformed
cells one or more of the major TM isoforms of higher
molecular weight are decreased or missing, while the levels of
one or more of the lower MrTM isoforms are increased. These
changes in TM expression appear to correlate well with the
rearrangement of microfilament bundles and morphological
alterations observed in transformed cells. The perturbations in
TM synthesis have been reported to occur in cells transformed
by a variety of agents including chemical carcinogens, UV
radiation, DNA and RNA tumor viruses. In addition, the
changes in TM expression following transformation occur in
cells of all species examined including chicken, rodents (mouse
and rat), and human, indicating that modulations in TM
expression are common features of the transformed phenotype
and thatTM genes may represent a target for oncogene action.
TMs are a family of actin-binding proteins that are expressed
in all eukaryotic cells. Different forms are expressed in muscle
(skeletal, cardiac, and smooth) and nonmuscle cells (reviewed
in refs. 14 and 15). Multiple forms of TM have been detected
in different cultures of nonmuscle cells, including rodent
fibroblasts (6, 7, 16), human fibroblasts (17, 18), and chicken
fibroblasts (4, 10, 19). Normal rat fibroblasts contain at least
seven isoforms of TM: three TMs of major abundance termed
1, 2, and 4 (apparent Mr = 40,000, 36,500, and 32,400,
respectively), and four relatively minor TMs termed 3, 5, 5a,
and Sb (apparent Mr = 35,000, 32,000, 32,000, and 32,000,
respectively) (6, 20, 21). The function of the multiple forms of
TM in nonmuscle cells remains to be established. Structural
differences however, do exist among the various protein
isoforms. These divergent regions correspond to functional
domains of the proteins including actin binding regions and
head-to-tail binding domains (reviewed in ref. 15).
Since biochemical studies suggest that TM plays a role in
stabilization of microfilaments in vivo, it is possible that the
altered patterns of TMs observed in many transformed cells
contribute to the alterations in actin filament assembly (re-
viewed in ref. 15). To determine if the suppression of TM
synthesis is essential in the establishment and maintenance of
the transformed phenotype we studied the effects of stably
expressing specific TM isoforms in a Kirsten virus-
transformed cell line. These cells do not express two high Mr
TM isoforms, namely, TM-2 and TM-3. Forced expression of
TM-2 or TM-3 in these cells lead to cell spreading and
formation of identifiable microfilament bundles, although
expression of each isoform resulted in distinct morphological
properties. In addition, cells expressing TM-2, but not TM-3,
exhibited contact inhibited cell growth and a requirement for
serum. These studies provide new information concerning the
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role of individual TM isoforms in the assembly of actin-based
suprastructures and their relationship to cell growth and the
aberrant morphology of transformed cells.
MATERIALS AND METHODS
Construction of Expression Vectors. The coding regions
derived from full-length cDNAs encoding rat fibroblast TM-2
and TM-3 (20) were modified with HindIII linkers and cloned
into the unique HindIII site located 70 bp downstream of the
transcriptional start site in the eukaryotic expression vector
pXKH (D. Hanahan, personal communication). The cDNA
contained the entire coding sequence and "20 bp of the
3'-untranslated region (UTR). The expression plasmid con-
tained the simian virus 40 (SV40) early promoter and the small
t intron and poly(A) site, respectively, flanking the TM cDNA.
Cell Culture, Transfection, and Clonal Selection. NRK 1570
and NRK 1569 cell lines were grown in DMEM supplemented
with penicillin (50 unit/ml), streptomycin (50 ,ug/ml), and 5%
fetal calf serum. Cells were grown at 37°C with 5% CO2
content. Stable lines were derived from the NRK 1569 cells by
cotransfection of TM constructs with pKoNeo (10:1 ratio),
using the calcium phosphate coprecipitation procedure. The
cells were incubated for 16-20 hr at 37°C, washed with PBS,
refed with fresh media, and incubated an additional 24 hr. The
transfected cells were then plated at various dilutions in media
containing G-418 (400 ,ug/ml). Drug-resistant colonies were
randomly selected after 7-10 days and cell lines were single cell
cloned to assure homogeneity. The derived cell lines were
maintained in medium containing G-418 (200 Ag/ml).
Immunoblot Analysis. Cells were grown on 60-mm plates to
"70% confluence, washed three times with PBS, and then
harvested in 1 ml of PBS by scraping with a rubber policeman.
The cells were recovered by centrifugation in a microcentri-
fuge and resuspended in 150 ml of Laemmli sample buffer, and
the lysate was boiled for 3 min. Lysates were resolved on
analytical SDS/12.5% polyacrylamide gels and analyzed by
Western blot analysis.
Immunofluorescent Staining. For immunofluorescence
cells were cultured on 12-mm glass coverslips. Cells were
washed and fixed in 3% paraformaldehyde as described (22).
Incubations with antibodies were performed in TBS (20 mM
Tris/154 mM NaCl/2 mM MgCl2/1 mM NaN3, pH 7.5).
Fluorescent images were photographed on a Zeiss Axiophot
using a X63 oil immersion lens and Kodak P3200 Tmax film.
Antibodies. Monoclonal anti-TM antibody (clone TM311),
anti-vinculin (clone hVinl), and anti-a-tubulin (clone DM 1A)
antibodies were from Sigma and monoclonal anti-pan-ras
(AB-3) was from Oncogene Science. Fluorescent labeled
secondary antibodies and phalloidin were purchased from
Molecular Probes.
Anchorage-Independent Growth and Growth in Low Se-
rum. Growth on soft agar assay was performed using 103, 104,
and i05 cells essentially as described (1). To determine the
ability of cells to grow in low serum 103, 104, and 105 cells were
plated on 60-mm plates in reduced (0.5%) serum and refed
every 3 days, and the cells were counted using Trypan blue.
Image Analysis. Random fields of subconfluent cultures
were photographed by phase contrast microscopy, and prints
were scanned into a Macintosh computer using the UMax UC
630 scanner. Areas of ~'-100 cells from a minimum of five
individual fields were measured for each cell line using the
IMAGE 1 software (Universal Imaging, Media, PA). The mean
area determined for each cell line in pixels squared for NRK
1570, 285.2 (SD = 12.7); NRK 1569, 21.5 (SD = 5.2); NRK
1569/TM-2, 208.3 (SD = 30.8); and NRK 1569/TM-3, 50.7
(SD = 5.5).
Two-Dimensional Gel Electrophoresis of Metabolically La-
beled Cells. Cells grown to 70% confluence in 60-mm culture
dishes were incubated for 16 hr in methionine-free DMEM
(GIBCO) in the presence of 100 ,uCi (1 Ci = 37 GBq) of
[35S]Met-translabel (New England Nuclear). [35S]Methionine-
labeled cells were solubilized and extracted in 9 M urea
(United States Biochemical), and soluble proteins were ana-
lyzed on isoelectric focusing gels (pH range 3-10) in the first
dimension and on SDS/slab 10% polyacrylamide gels in the
second dimension as described by Garrels (23) with the
modifications given by Patterson and Latter (24). Gels were
dried and exposed to x-ray films for 7-14 days.
RESULTS
Stable Expression of TM-2 and TM-3 in the Kirsten Virus-
Transformed Cell Line (NRK 1569). The Kirsten virus-
transformed cell line (NRK 1569) expresses no TM-2 and
TM-3 protein or mRNA and has reduced levels of TM-1
protein (6, 20). These cells have a rounded morphology and are
devoid of microfilament bundles. We have used constructs
containing full-length cDNAs for TM-2 and TM-3 and driven
by the SV40 early promoter to express them in these cells.
These constructs contain the entire coding region, the authen-
tic stop codon with 20 bp of 3'-untranslated sequence, and a
functional splice site (small t intron) as well as a poly(A)
addition site downstream of the TM cDNA sequences. Plas-
mids encoding TM-2 or TM-3 were cotransfected with a
pKO-neo plasmid that contains a neomycin-resistant gene into
NRK 1569 cells. Cells were selected based on resistance to
G-418. Single colonies were expanded and analyzed for ex-
pression of TM, morphological changes, and cytoskeletal
rearrangements. The expression of TM-2 or TM-3 proteins in
the NRK cells was determined by Western blot analysis of cells
expressing the neomycin-resistant plasmid alone, three inde-
pendent clones expressing the TM-2 plasmid, and three inde-
pendent clones expressing the TM-3 plasmid (Fig. 1). The only
high Mr TM isoform detected by antibody 311 in NRK 1569
cells stably transfected with Neo alone is TM-1 (Fig. 1, lane H).
As shown in lanes B-G the clones that were isolated have a
range of expression levels of TM-2 or TM-3.
To confirm that the expressed isoforms represent authentic
TM-2 and TM-3, the cells were labeled in vivo with [35S]me-
thionine for 16 hr, and total cell lysates were analyzed by
two-dimensional gel electrophoresis (Fig. 2). New spots, cor-
responding to the positions of endogenous TM-2 (Fig. 2b) or
TM-3 (Fig. 2c) appeared in the respective clones and were
positively identified by Western blot analysis using a mono-
clonal TM antibody (data not shown). To confirm further that
the stable lines still expressed the viral ras gene product, cell
lysates were analyzed by Western blot analysis and the expres-
sion of v-ras was confirmed using a pan-ras antibody (data not
shown).
Expression of TM-2 and TM-3 Results in Cell Spreading
and Distinct Effects on the Actin Cytoskeleton. To determine
if expression of TM-2 or TM-3 had an effect on cell morphol-
ogy the parental cell line NRK 1569 was compared with cells
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FIG. 1. Stable expression of TM-2 and TM-3 in NRK 1569 cells.
Cell lines successfully cotransfected with the SV40-TM-2 or SV40-
TM-3 and pKO-neo plasmids were grown. Whole cell lysates from the
cell cultures were analyzed by Western blot analysis using mAb to TM
(Sigma, clone TM311) that recognizes only the high Mr TM isoforms
TM-1, TM-2, and TM-3 in fibroblasts. Lane A, mixture of purified
TM-1, TM-2, and TM-3 for control; lanes B-D, whole cell lysates from
clones 2.1, 2.6, and 2.10, respectively; lanes E-G, whole cell lysates
from clones 3.4, 3.7, and 3.9, respectively; and lane H, lysate from clone
neo.1 of NRK 1569 cell expressing the neomycin-resistance plasmid
alone.
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FIG. 2. Two-dimensional gel electrophoresis of cells expressing TM-2 or TM-3: Autoradiographs of parental NRK 1569 cells with no detectable
TM-2 or TM-3 proteins (a), NRK 1569 cells expressing TM-2 (b), or NRK 1569 cells expressing TM-3 (c). Similar results were obtained for all
three clones expressing TM-2 or TM-3. The positions of the TMs are indicated by numbers, and the position of the major actin spot is indicated
by act.
expressing TM-2 or TM-3 and with the untransformed cell line
NRK 1570. In contrast to the NRK 1570 cells that exhibit a
classic, fibroblast-like phenotype (Fig. 3B), the NRK 1569 cells
have adopted a rounded morphology (Fig. 3A) with cell
spreading of <10% of the values obtained with untransfected
1570 cells. Cells expressing TM-3 spread to "18% of the value
measured for the NRK 1570 cells (Fig. 3C). TM-2 expressing
clones, by contrast, exhibited substantial cell spreading regain-
ing on average 75S% of the 1570 phenotype when cell
spreading was used as a measure to define phenotypic rever-
sion (Fig. 3D).
We next determined if cell spreading was accompanied by
changes in the organization of actin. Actin filaments were
visualized by fluorescence microscopy using rhodamine-
labeled phalloidin. Individual actin filaments are noticeably
absent from the parental 1569 cell line (Fig. 4A), compared
with the well-developed stress fibers observed in the untrans-
formed control NRK 1570 cells (Fig. 4b). NRK 1569 cells
stably expressing TM-2 or TM-3 exhibited identifiable micro-
filament bundles, although they were more prominent in the
cells expressing TM-2 compared with those expressing TM-3
(Fig. 4 c and d). In addition, the NRK 1569 cell clones
expressing TM-3 also exhibited patches of actin-filaments
localized to one region of the cell (Fig. 4d). Identical results
were found for all independent cell lines expressing TM-3
(data not shown).
Since expression of TM-2 and TM-3 resulted in changes in
cell shape and organization of actin, we also examined the
distribution of vinculin and tubulin in these stable cell lines. In
TM-2 expressing clones the formation of well-developed focal
adhesions could be observed that colocalized with actin at the
ends of stress fiber bundles (Fig. SC). In the untransfected
NRK 1569 cells vinculin was observed to be concentrated in
the area of high actin concentration at the periphery of the
cells (Fig. SA) but did not get organized into prominent
adhesion plaques. Similarly to NRK 1569 cells, TM-3 clones
exhibited a reduced degree of actin stress fiber formation and
contained areas of "actin-disorganization" resembling in part
NRK 1569 phenotype. In agreement with the low level of stress
fiber organization in TM-3 clones, the distribution of vinculin
was less well-defined in these cells (Fig. SD). Since cells
expressing TM-2 and TM-3 exhibit a somewhat different
distribution of actin, it was of interest to determine if differ-
ences would be observed for the distribution of microtubules.
In contrast to the actin cytoskeleton, the microtubular appa-
ratus appeared similar in both cell lines expressing TM-2 or
TM-3 (Fig. 6). In the areas of "actin disorganization" present
in the TM-3 clones (Fig. 6c), microtubules could be observed
FIG. 3. Stable expression ofTM-2 or TM-3 in NRK 1569 cells leads to cell spreading. Cell spreading was monitored by phase contrast microscopy
3 days after plating. (A) NRK 1569, (B) NRK 1570, (C) cells from clone 3.9 expressing the SV40-TM-3 plasmid, and (D) cells from clone 2.10
expressing the SV40-TM-2 plasmid. (Bar = 100 ,Lm.)
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FIG. 4. Stable expression-ofTM-2 or TM-3 in NRK 1569 cells leads
to the formation of microfilament bundles. Microfilaments were
visualized using rhodamine-phalloidin. (a) NRK 1569 cells; (b) NRK
1570; (c) clone 2.6; and (d) clone 3.9. Note the similar degree of
disorganization of the actin in the cell periphery ofNRK 1569 cells and
in areas of clone 3.9 (arrow in d). (Bar = 15 ,um.)
to penetrate these regions without noticeable alterations (Fig.
6d).
Growth Properties. Since overexpression ofTM-2 and TM-3
led to partial morphological reversion of the transformed
phenotype it was of interest to determine whether these
changes in cell shape and cytoarchitecture were accompanied
by changes in other properties of the transformed cells includ-
ing density and anchorage-independent growth and the ability
to grow in low serum. As indicated in Table 1, all clones
exhibited the same, unaltered ability to grow in soft agar,
demonstrating the ability for anchorage-independent growth
was retained in these cells even afterTM transfection. We next
determined if the cells expressing TM-2 or TM-3 would be able
to grow in low serum. Interestingly, each of three independent
cell lines expressing TM-2 was no longer able to grow in
conditions of low serum (Table 1), whereas cells expressing
TM-3 retained their ability to grow in low serum. Finally, we
determined if the expression of TM-2 or TM-3 had effects on
density-related growth. All clones expressing TM-2 were ob-
served to grow to a confluent monolayer upon prolonged
cultivation resulting in a subsequent decrease in cell growth.
This is indicative of a restoration of contact inhibition as can
be found in normal fibroblasts. In contrast, TM-3 clones did
not form a monolayer and showed no signs of density regulated
cell growth, thus exhibiting a growth characteristic comparable
to the transformed NRK 1569 cell line.
DISCUSSION
We report in this study that the expression of TMs in cells
transformed with viral oncogenic ras can rescue the normal
Table 1. Growth characteristics of tropomyosin-expressing cell lines
Expressed Density-
exogenous Growth in Growth in independent
Clone genes soft agar low serum growth
0.1 Neo + + +
2.1 Neo, TM-2 + - -
2.6 Neo, TM-2 + - -
2.10 Neo, TM-2 +
3.4 Neo, TM-3 + + +
3.7 Neo, TM-3 + + +
3.9 Neo, TM-3 + + +
fibroblastic phenotype and demonstrate the possibility of
circumventing the effects of ras in vivo by expression of
cytoskeletal proteins from a plasmid. We also show that TM-2
and TM-3 exhibit differential potential for this phenotypic
reversion suggesting distinct cellular roles for these two iso-
forms. These results raise a number of questions including: (i)
Do changes in expression of TM play a causal role in trans-
formation? (ii) How does expression ofTM lead to alterations
in microfilament structure? (iii) Why do different isoforms
exhibit different phenotypic effects?
We are only starting to understand the possible direct
relationship between expression (or modulation) of actin-
associated proteins and the acquisition of a transformed
phenotype. With respect to the role of TM expression in
transformation, a number of studies have reported that ex-
pression of TM coding or noncoding sequences can revert
some of the properties of the transformed phenotype. In a
recent study it was found that increased expression of fibro-
blast TM-1 in a v-Ki-ras-transformed 3T3 cell line was accom-
panied by cell spreading, induced anchorage-dependence cell
growth, and inhibition of tumor-forming capabilities when
compared with the parental cell line (25). Although the level
of TM-1 expression is reduced by 50% in the transformed 3T3
cells and expression of TM-2 is below detectable levels,
increased expression of TM-1 was able to revert some of the
features of the transformed phenotype. In another study of a
v-raf-transformed rat cell line that exhibits largely reduced
levels of TM-1 and TM-2, expression of TM-2 resulted in the
restoration of microfilament bundles, but did not affect the
rate of cell growth or the ability to grow in soft agar (26). These
data are similar to the results obtained in the present study
where we observed that cells expressing TM-2 or TM-3
exhibited an increased formation of microfilament bundles but
were still able to grow on soft agar. Collectively these results
demonstrate that increased expression of any of the high Mr
TM isoforms (TM-1, TM-2, and TM-3) is sufficient to induce
cell spreading and actin filament organization, but exhibit
differences in their ability to alter other properties of the
transformed phenotype. Recently it was reported that expres-
sion of an antisense RNA to TM-1 led to a reduction of TM-1
protein and disorganization of microfilaments (27). Thus
changes in the levels of one isoform could affect filament
dynamics.
Since we could not detect any noticeable changes in the
expression levels of other cytoskeletal components or of actin
itself following the expression of TM-2 or TM-3, the reported
effects on the restoration of stress fiber bundles might reflect
alterations in the state of assembly or in the composition of the
microfilaments. Rodriguez-Fernandez et al. (28) have reported
a similar mechanism for the assembly of adhesion complexes
following the modulation of vinculin expression in 3T3 cells
and suggested a relation between the organization state of
microfilaments and focal adhesion. Our results with high Mr
TMs support this assumption and demonstrate that alterations
in microfilament organization may influence the assembly of
cell-substrate contact sites. It is worth noting that clones
having spontaneously lost their transgene after a number of
passages reverted to the original transformed phenotype and
were indistinguishable from NRK 1569 cells in terms of their
morphological a-s well as their growth characteristics (data not
shown). Spontaneous reversion in phenotype with concomi-
tant disorganization of microfilaments were observed by oth-
ers in similar studies (28-30). These phenotypic reversions
further support the conclusion that the effects seen in the TM
clones are due to the presence of the TM proteins in the cell
expressed from the transgene.
In addition to effects obtained following expression of
coding sequences for TMs, a role for the 3'-untranslated
sequences (3'-UTRs) in TM mRNAs has been reported (31).
Recent work by Blau and coworkers (31) reported that a
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FIG. 5. Cells expressing TM-2 reform focal adhesion contacts. Focal adhesion contacts were visualized using a monoclonal anti-vinculin antibody.
(A) NRK 1569 cells; (B) NRK 1570; (C) clone 2.6; and (D) clone 3.9. Note the well-defined vinculin-containing focal adhesion sites in B and C
at the periphery of both cell lines (arrowheads) and anchorage sites at the basal surface of the 1570 cells (arrows in B).
portion of the 3'-UTR of the a-TM gene functions as a
"riboregulator." When this region was stably expressed in a
myogenic cell line (NMU2), this RNA was sufficient for the
suppression of anchorage-independent growth and the sup-
pression of tumor formation. The constructs used in experi-
ments that demonstrate expression of TM-1 in the v-Ki-ras-
transformed 3T3 cells do have the 3'-UTR of the mRNA (25).
These results are in contrast to those obtained with the cDNA
constructs used in the v-raf-transformed cells (26) and in the
present study that do not contain this region in the mRNA.
Thus, many of the phenotypic changes may be attributed to the
expression of protein and not to sequences present in the
3'-UTRs. There are some questions about the general effects
of 3'-UTRs in transformation since these sequences are com-
mon to more than a single mRNA for TM. For example, in the
case of the v-Ki-ras-transformed cells used in this study,
although these cells generate neither mRNA nor protein for
FIG. 6. Double-label immunofluorescence to analyze the distribu-
tion of microfilaments and microtubules in cells expressing TM-2 or
TM-3. Microfilaments were visualized using rhodamine-phalloidin (a
and c) and microtubules were visualized using a monoclonal anti-a-
tubulin antibody (b and d). (a and b) Clone 2.6; (c and d) clone 3.4.
(Bar = 15 ,um.)
TM-2 and TM-3, they still express detectable levels of TM-5a,
which is also the product of the a-TM gene and contains the
same 3'-UTR (20). In addition, a number of TM isoforms
containing the same 3'-UTRs (TM-2, TM-3, TM-5a, and
TM-Sb) are sometimes up-regulated in transformation. An
adenovirus transformed cell line has been characterized that
expresses elevated levels of TM-2, TM-3, TM-5a, and TM-Sb,
all products of the a-TM gene. Therefore, down-regulation of
sequences present within the 3'-UTR of TM mRNAs cannot
fully explain the effects associated with TM in transformation.
The ability of TM-2 and TM-3 to exhibit different effects on
cytoarchitecture and growth properties shown in the present
study are unlikely to be due to differential localization of these
isoforms, since previous studies have demonstrated that these
isoforms exhibit identical cellular localization patterns in
fibroblasts (32). TM-2 and TM-3 are both expressed from the
a-TM gene via alternative RNA splicing, and differ by the use
of a single exon, exons 6b and 6a, respectively (20). How the
use of these exons can contribute to the differences observed
remains to be determined. The different effects observed are
not simply due to differences in the levels of the expressed
proteins since each isoform was expressed to similar levels in
the cells lines established and the effects were seen regardless
of the amount expressed. Previous studies of TM-2 and TM-3
indicated no significant differences in their relative affinities
for F-actin (32).
Although expression of TM can result in cell spreading and
the formation of prominent microfilaments, more work will be
required to determine more precisely the role of TM in
transformation. Perturbations in the integrity of the cytoskel-
eton could lead to global effects by interfering normal signal-
ing pathways. -Whether expression of TM-2 will suppress
tumorigenicity will have to be determined in future studies.
However, the ability of these cells to grow on soft suggests that
will not be the case since this assay is a good indicator of
tumorigenicity (1, 33). While changes in TM are common in
many transformed cell lines, it is unresolved whether TM gene
expression is a target of oncogene action or is an indirect
consequence. In one study using a rat-1 cell line that contained
a temperature sensitive src, changes in TM expression and cell
shape were observed at the permissive temperature and re-
turned to normal at the nonpermissive temperature (6). Thus,
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at least in this case, it appears that TM expression is likely a
target of oncogene action. How TM can overcome or circum-
vent the effects of ras or other oncogenes in the presence of
their action is not known. Work currently in progress focuses
on the elucidation of a possible direct interaction between
oncogenic ras and TM and the involvement of components of
the actin cytoskeleton in the complex events of signal trans-
duction. In recent years a number of studies have demon-
strated that expression of structural proteins such as vinculin
(30), and a-actinin (34, 35) can suppress tumorigenicity in
transformed cells, demonstrating the importance of structural
proteins in the transformed phenotype. Further work will be
required to address the relationship of alterations in cytoskel-
etal protein expression and transformation. Such studies will
provide important information for the role that the cytoskel-
eton plays in normal and aberrant cell signaling.
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